{"name":"Summit Therapeutics","slug":"summit-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOOVNFUmRlV1Jta3JWWloyZHo0R2hiMTd2dUU1RWd0UVR6SXVFSkFUTlBtTlhEQTZlYTVBZDVYQ3FUNkpPa05Bc2lzNTYwS3YtUy1seERsNDJlX3hseDM2aWVEb2ZraGlLblNIQkNxMTVIN01xeFFpTnNVeGRIb0doN1FZaGkwR25zUlhnOU1acWVtV0dvWW4zdg?oc=5","date":"2026-03-25","type":"pipeline","source":"The Motley Fool","summary":"Prediction: 2 Stocks That Will Be Worth More Than Summit Therapeutics 1 Year From Now - The Motley Fool","headline":"Prediction: 2 Stocks That Will Be Worth More Than Summit Therapeutics 1 Year From Now","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxOZzhwR1pzamVxaTVIR3VZeC1lZC01dWUzZ2hqb1Fqc01DcFFwOUlTVmR1dHlpMmVwbVIzT0hja01UR1RWX0dIYXM3NjZtXzI4VG56dEF1N05Hc01mOTQtUzA4a1FmdXE1cmhNVFYyMzZVbFVkejRQb0QxSXVVeG1yeDZVTmlIZjRYQk9YR1dEaHU1MjJYMlB6NFhxeG5zbEtkWWZLbWxOR0VvVzJWcV9wN1JnWExTQ0hvdEx5RHFkVkxqUm8?oc=5","date":"2026-03-16","type":"pipeline","source":"Fierce Pharma","summary":"J&J files trade secret lawsuit against former oncology employee linked to Summit Therapeutics - Fierce Pharma","headline":"J&J files trade secret lawsuit against former oncology employee linked to Summit Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxPT0ZoZXg5ZDZDZHVOQmFWa3VXTTJYc0VsUTFCdVZ0dFJaclQ5MjJCbl9QUk12ZUVseENQaVRndVpJdjdlWVl6WkdPMGhYcXlYRjVJQzBrTGZuaWJBSWFnVGxQWk1jRWpta0J6RzBZSEl5RFowUXFuOGxFbl90N25LNnhB?oc=5","date":"2026-01-30","type":"regulatory","source":"pharmaphorum","summary":"FDA starts review of Summit's VEGFxPD-1 bispecific - pharmaphorum","headline":"FDA starts review of Summit's VEGFxPD-1 bispecific","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-29","type":"regulatory","source":"Business Wire","summary":"Summit Therapeutics Announces U.S. FDA Acceptance of Biologics License Application (BLA) Seeking Approval for Ivonescimab in Combination with Chemotherapy in Treatment of Patients with EGFRm NSCLC Pos","headline":"Summit Therapeutics Announces U.S. FDA Acceptance of Biologics License Application (BLA) Seeking Approval for Ivonescima","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFA5VmtlVE85dHVRV19WY1U1dkV0OG9mclpHREF6ay1FdEJ1aklEMk16cFJNbzRuNTY1V2RIa3RvLUcyX09aYkxYWDBxd1F0VF9aSjU4?oc=5","date":"2026-01-29","type":"regulatory","source":"FirstWord Pharma","summary":"FDA starts review clock for Summit, Akeso's PD-1/VEGF bispecific - FirstWord Pharma","headline":"FDA starts review clock for Summit, Akeso's PD-1/VEGF bispecific","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQVUt3UlZOTmNCTjRSYkFZeXdHc3JKVGlhU0Zod0pvZGJEV0JpWDZIWjRERzlTNlhNdXljZ1pkNGtvSUdXM3ZpZWpwOW85dE9haTZMMVRJQkk0YksyR3h0T0dSR1piNl9GRHhBdnRLeks4MnFNQkFUNXNtZ1JTbktCa2RPWVlzSXQxUFdtUnRyRWRNNDBhOFdZ?oc=5","date":"2025-12-03","type":"deal","source":"The Motley Fool","summary":"Don't Buy Summit Therapeutics Until This Big Thing Happen - The Motley Fool","headline":"Don't Buy Summit Therapeutics Until This Big Thing Happen","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxOT2F3ekNBWEtKT3Y4SkFkaGV6YkRmWkxsUDlpaVh6WXNtdms0dElyUUdvZE9ySkNucm0tWGcyb2hBa193WVdobkRkMUdtVWltVDFrRE8wdXE5aFdJM3p6MzZ1X3hiTHNLdTMzekdhSVdRMkJhNUk3UkdYSDIwZkd3RWx1NVc5NlFJdzhYSWl4SGMyMmh0LXF6dDBJODdldTU0NWFQa1NLbjJaLWZOODFYYVBITWxsdm8?oc=5","date":"2025-11-11","type":"pipeline","source":"Fierce Biotech","summary":"With Summit leading the pack in PD-1xVEGF bispecifics, Pfizer lays out its own plan to replace Keytruda - Fierce Biotech","headline":"With Summit leading the pack in PD-1xVEGF bispecifics, Pfizer lays out its own plan to replace Keytruda","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE1sMGVhR0pxdzQ2MXlsVDUzTFM3NENFbXhQRHc0dDdBTUk0WVNYU2luZHlEUjlqNzRWTFUwYklTQUc2TjFRYWRYajBENEV0cFZwVjgw?oc=5","date":"2025-10-20","type":"regulatory","source":"FirstWord Pharma","summary":"Summit to push lung cancer hopeful ivonescimab toward FDA despite lack of OS win - FirstWord Pharma","headline":"Summit to push lung cancer hopeful ivonescimab toward FDA despite lack of OS win","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQX09kRjFmb21ERnBEYmNKdHBYN2xjaEFFUXNJVGJQRF9HZzFxTmwwVnhXUFpTS0dOdDBQWEtzWXRvTHRIMFlybkJ1LVZib0ZhOVkyZW9pR3YySy1JYm9OZF8zbzhoeU5JLTZ5TFJtM2xhMTVyTVQ5LVgxcm1URi0xNkdtelBJUFNoeVliNndHNDdFQ3FqMU1B?oc=5","date":"2025-09-10","type":"pipeline","source":"Fierce Pharma","summary":"Editor's Corner—For the first PD-1xVEGF's sake, Summit must submit to Big Pharma, stat - Fierce Pharma","headline":"Editor's Corner—For the first PD-1xVEGF's sake, Summit must submit to Big Pharma, stat","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxNTjJlYV9zQnZaUDJDc2tNSHNuZWJiYVp2ZjhuSy1WS0FXd2M1OGk0bWwzRi1pbndGa09yZ0kyY2RPdE9hZm9Sa2FtMGxCeXlFWndScnZJUGVyLUY3bE1LVXJuTzZ6QlBERjA1NERhcHE2TjRPNVVOMkVwT05pM1hlQ0Z1ZkIxdWM?oc=5","date":"2025-09-07","type":"pipeline","source":"statnews.com","summary":"Summit Therapeutics hits possible snag on lung cancer drug seen as a blockbuster - statnews.com","headline":"Summit Therapeutics hits possible snag on lung cancer drug seen as a blockbuster","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNNXd5dkd3NHM2NjdoUnBUbnZXd29rQXNZQ3N5dll3ZHdQX1ltOV9qNS1RZ2xoLXFnSGM5ZFBLQTc4aGJUTlBqZG1DTHpGLUI3YVdEWjQ2YTFUbG40WjF4V01pRnozaEJReFdBOU41ZjA0R0szYnMzNzFOSml2bVZMMVk3YXc2MjBlQTlDWW1lVG9QNExpcXhrS0Y0UjEzQQ?oc=5","date":"2025-08-12","type":"earnings","source":"Fierce Pharma","summary":"Summit skips routine quarterly investor call as deal rumors swirl - Fierce Pharma","headline":"Summit skips routine quarterly investor call as deal rumors swirl","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxQVTJ2bXhXTUxycUxTX2VyQ09iMnRoREViU2FzMEp5M0xMRkc5Q3daTksxQjdxQjVuMldWTlRhekZNNDRRRjJYaXBEQTRxaTJRWFR1ekU4dFhIajVIcWN2VzROQVFCZGFJYTVNZ19EOXEwaGlVVHBobWlTSVhtT1dUMzVFVTg4OWNTRzZsOTZVMzZGQjhxLXkxM3RyUTQ1YmpVVFlPNl9qc0s5SHlpZUNKNnZkUnd6U0tucDVsVUFSdHFiU0NDREczcE90WXhxNFFieW92eUM0ZXpMTWpjOGpr?oc=5","date":"2025-07-03","type":"deal","source":"reuters.com","summary":"Summit, AstraZeneca in talks over $15 billion cancer drug licensing deal, Bloomberg News reports - reuters.com","headline":"Summit, AstraZeneca in talks over $15 billion cancer drug licensing deal, Bloomberg News reports","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}